Design, synthesis, and molecular modelling of pyridazinone and phthalazinone derivatives as protein kinases inhibitors

33Citations
Citations of this article
40Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The design and synthesis of pyridazinone and phthalazinone derivatives are described. Newly synthesized compounds were tested on a panel of four kinases in order to evaluate their activity and potential selectivity. In addition, the promising compounds were tested on four cancer cell lines to examine cytotoxic effects. The compounds inhibited DYRK1A and GSK3 with different activity. SAR analysis and docking calculations were carried out to aid in the interpretation of the results. Taken together, our findings suggest that pyridazinone and phthalazinone scaffolds are interesting starting points for design of potent GSK3 and DYRK1A inhibitors. © 2013 Elsevier Ltd. All rights reserved.

Cite

CITATION STYLE

APA

Elagawany, M., Ibrahim, M. A., Ali Ahmed, H. E., El-Etrawy, A. S., Ghiaty, A., Abdel-Samii, Z. K., … Bajorath, J. (2013). Design, synthesis, and molecular modelling of pyridazinone and phthalazinone derivatives as protein kinases inhibitors. Bioorganic and Medicinal Chemistry Letters, 23(7), 2007–2013. https://doi.org/10.1016/j.bmcl.2013.02.027

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free